Self-replicating RNAs (replicons), with or without reporter gene sequences, derived from the genome of the Paderborn strain of classical swine fever virus (CSFV) have been produced. The full-length viral cDNA, propagated within a bacterial artificial chromosome, was modified by targeted recombination within Escherichia coli. RNA transcripts were produced in vitro and introduced into cells by electroporation. The translation and replication of the replicon RNAs could be followed by the accumulation of luciferase (from Renilla reniformis or Gaussia princeps) protein expression (where appropriate), as well as by detection of CSFV NS3 protein production within the cells. Inclusion of the viral E2 coding region within the replicon was advantageous for replication efficiency. Production of chimeric RNAs, substituting the NS2 and NS3 coding regions (as a unit) from the Paderborn strain with the equivalent sequences from the highly virulent Koslov strain or the vaccine strain Riems, blocked replication. However, replacing the Paderborn NS5B coding sequence with the RNA polymerase coding sequence from the Koslov strain greatly enhanced expression of the reporter protein from the replicon. In contrast, replacement with the Riems NS5B sequence significantly impaired replication efficiency. Thus, these replicons provide a system for determining specific regions of the CSFV genome required for genome replication without the constraints of maintaining infectivity.
INTRODUCTION
Classical swine fever virus (CSFV) causes a severe, highly contagious disease in swine (family Suidae). Infection can lead to a fatal outcome and outbreaks of disease result in important socioeconomic losses worldwide (Terpstra & de Smit, 2000) . CSFV is a member of the genus Pestivirus, as are bovine viral diarrhea virus (BVDV) and border disease virus. The pestiviruses are related to members of the genera Flavivirus (e.g. yellow fever virus) and Hepacivirus (e.g. hepatitis C virus, HCV) and together form the family Flaviviridae (Lindenbach et al., 2007) . The CSFV genome is a positive-sense, ssRNA molecule of approximately 12 300 nt. The genome includes a single, large ORF, which encodes a polyprotein of approximately 3900 aa, that is flanked by UTRs. The genome is uncapped at its 59 terminus and the 59 UTR contains an internal ribosomal entry site (IRES), which directs cap-independent translation initiation on the viral RNA (Fletcher & Jackson, 2002; Friis et al., 2012) . The 39 UTR is unusual, compared with most eukaryotic mRNAs, in that it lacks a poly(A) tail but is predicted to contain a variety of structural elements that are involved in initiating the synthesis of negativesense strands (Deng & Brock, 1993; Frolov et al., 1998; Pankraz et al., 2005; Yu et al., 1999) . The viral RNA genome is infectious, and thus introduction of the RNA into cells is sufficient to initiate the infection cycle; this involves translation of the RNA to produce the viral proteins and then subsequent replication of the genome mediated by some of these proteins.
The viral polyprotein is co-and post-translationally cleaved, by cellular and virus-encoded proteases, to produce four structural proteins (the core protein, C, and three envelope proteins, E rns , E1 and E2) plus eight non-structural proteins (N pro , p7, NS2, NS3, NS4A, NS4B, NS5A and NS5B) (Meyers & Thiel, 1996; Rümenapf et al., 1993; Weiland et al., 1990) .
Replicons are replication-competent RNA molecules that are incapable of generating infectious progeny virus due to loss of one or more structural proteins (e.g. E1 or E2). Early work on subgenomic pestivirus replicons was performed using transcripts based on BVDV (Behrens et al., 1998; Reimann et al., 2003; Tautz et al., 1999; Yu et al., 1999) and CSFV (Mittelholzer et al., 1997; Moser et al., 1999) genomes. In these studies, it was shown that the CSFV and BVDV structural proteins C, E rns , E1 and E2 and also the nonstructural proteins N pro , p7 and NS2 are non-essential for genome replication. Thus, the genome sequences encoding NS3-NS5B together with the 59 and 39 UTRs are the minimal elements required for autonomous pestivirus RNA replication. The NS3 and NS5B proteins have key roles in replication, including processing of the polyprotein and as the RNA-dependent RNA polymerase (RdRp), which synthesizes new viral RNA, respectively.
The presence of a reporter protein coding sequence within a replicon facilitates quantitative assessment of the replication competence of a particular RNA species. Reporter proteins such as Renilla reniformis luciferase (Rluc) and firefly luciferase have been widely used for the quantitative assessment of protein expression (reviewed by Greer & Szalay, 2002) . Recently, another luciferase protein from Gaussia princeps (Gluc) has been described (Tannous et al., 2005) ; this protein is secreted from cells and can be assayed using the cell supernatant without cell lysis. The Gluc protein, in tandem with a downstream foot-and-mouth disease virus (FMDV) 2A peptide, has been shown to yield a functional luciferase from an HCV-derived replicon (Jones et al., 2007) .
Swapping corresponding protein coding sequences between related viral strains, thereby forming chimeric RNAs, provides a strategy to identify important interactions between different components of the replication machinery. Indeed, previous studies using HCV replicons showed that exchanging the RdRp from strains with different replication efficiencies could greatly enhance or impair replication (Binder et al., 2007) .
The Paderborn strain of CSFV has been characterized as being moderately virulent ; the virus was isolated from the devastating outbreak of classical swine fever (CSF) in the Netherlands in 1997 Widjojoatmodjo et al., 1999) . A full-length cDNA amplicon, derived from the Paderborn virus, was introduced into a stable, single-copy, bacterial artificial chromosome (BAC). Following in vitro transcription and introduction of the RNA into cells, recovery of infectious CSF viruses from this cDNA was achieved .
Using this CSFV cDNA as a backbone, multiple replicons either with or without reporter protein coding sequences have now been produced. In addition, chimeric replicons have been made that contain coding sequences, for selected viral proteins, exchanged between CSFV strains of distinct virulence and the effect on the replication efficiency has been determined.
RESULTS

Design of CSFV replicons
The pBeloPader10 BAC, including the complete cDNA of the Paderborn strain of CSFV, can be used to make RNA transcripts that are able to replicate and produce infectious virus within cells . Modifications to this CSFV cDNA have been achieved using targeted recombination, which avoids the need for convenient restriction enzyme sites or subcloning and permits the modification of any region of the cDNA sequence. Two different types of in-frame deletion have been made within the Paderborn cDNA. In rPad1, nt 896-3541 of the CSFV cDNA were deleted and this removed most, or all, of the coding sequence for the C, E rns , E1 and E2 proteins. A second, smaller deletion (in rPad2) removed nt 974-2329, which resulted in the loss of part, or all, of the C, E rns and E1 coding sequences but left the E2 coding region intact (Fig. 1) . In addition, using the same targeted recombination approach, the Rluc-2A coding sequence (a fusion of the Rluc with the FMDV 2A peptide coding sequences) has been inserted at the site of these deletions to produce the reporter replicons rPad1RL and rPad2RL, respectively (Fig. 1) . In each case, an intact ORF has been maintained so that the non-structural proteins, which are required for RNA replication, can be produced. The FMDV 2A sequence (only 18 aa in length) generates a cotranslational cleavage at its own C terminus at an NPG/P junction (Donnelly et al., 2001) . Thus, the protein sequences, downstream of the 2A sequence, are freed from the reporter protein and should be functionally unmodified [a slight caveat to this is that the N terminus of the downstream protein will be a proline (P) residue]. The complete sequences of the BACs containing these four different replicon cDNAs have been verified (data not shown).
Functional analysis of replicons
To assess the replication competence of these four replicons, RNA transcripts derived from the parental BAC (pBeloPader10) and from the replicon derivatives were produced, in vitro, and introduced into sheep fetal thymus (SFT-R) cells by electroporation. After 24 h, cells were stained for the presence of the CSFV E2 and NS3 proteins using immunofluorescence assays (Fig. 2) . No expression of these proteins was detected in mock-treated cells. However, the transcripts derived from the parental pBeloPader10 expressed both the E2 and the NS3 proteins in the cytoplasm of the cells. Furthermore, if these cells were harvested and the material passaged onto fresh cells, then these cells also expressed the E2 and NS3 proteins (data not shown) due to the production of infectious virus (Friis et al., 2012; Rasmussen et al., 2010) . Each of these four replicons expressed the NS3 protein in the cytoplasm of cells (Fig. 2) indicating that they were functional. In addition, both rPad2 and its derivative rPad2RL produced the E2 protein (Fig. 2) , as these contain the E2 coding sequence (Fig. 1) . However, in contrast, no signal indicative of E2 expression was detected from the rPad1 and rPad1RL transcripts as these both lack the E2 coding sequences. No spread of the NS3 or E2 protein expression to adjacent cells was observed (data not shown), as no infectious virus progeny are formed.
Expression of reporter proteins by replicons
The replicons rPad1RL and rPad2RL contain the Rluc-2A coding sequence. It was necessary to determine that the replicon sequences expressed a functional Rluc and that this expression reflected RNA replication. RNA transcripts were produced in vitro from amplicons generated from the BACs and introduced into SFT-R cells using electroporation. As a negative control, a derivative of rPad2RL was produced lacking a portion of the NS5A and NS5B coding sequence; this construct was termed rPad2RLD (Fig. 1) . RNA transcripts were also produced from this construct and were assayed in the same way. Cell extracts were prepared 3, 12 and 24 h after electroporation and assayed for Rluc activity (Fig. 3) . Luciferase activity was observed at 3 h from each of these RNAs, presumably reflecting translation of the input RNA. At this time, about a 100-fold increase in Rluc values compared with mock-treated cells (background) was observed. A further increase in luciferase expression was observed at 12 or 24 h in cells that received the rPad1RL and rPad2RL transcripts. In contrast, no increase in luciferase activity was observed from the rPad2RLD transcripts. Thus, the enhanced signal seen at 12 or 24 h was dependent on the ability of the RNA to be replicated. It was consistently found that higher levels of Rluc activity were obtained with the rPad2RL replicon than with the rPad1RL (Fig. 3) . Packaging of the replicon rPad2RL into virus-like particles, which can initiate a single cycle of infection, can be achieved using the RNA from pBeloPader10 cDNA as a helper. The supernatant from cells electroporated with the replicon rPad2RL transcript together with the pBeloPader10 transcript was passaged onto naïve cells and produced Rluc within these cells, thereby indicating spread of the packaged replicon (data not shown).
To characterize the nature of the Rluc protein expressed from the rPad1RL and rPad2RL replicons, cell extracts were prepared at 24 h post-electroporation and analysed by immunoblotting (Fig. 4) . As a loading control, anti-actin antibodies were used and detected actin in all the cell extracts. In contrast, no products were detected using antiRluc antibodies in mock-treated cells or from cells that received the rPad1 and rPad2 replicons (without the Rluc sequence). However, Rluc-related products of 38 and 41 kDa were detected within cells that received the rPad1RL and rPad2RL replicons, respectively (Fig. 4) . The Rluc-related products expressed from these replicons ought to have the Rluc protein fused to the residual portions of the C protein but should be released from downstream sequences by the action of the FMDV 2A peptide (Fig. 1) . The predicted sizes of the products were 335 aa (~37 kDa) and 361 aa (~40 kDa) for rPad1RL and rPad2RL, respectively, which corresponded well to the observed products (Fig. 4 ).
An alternative derivative of the rPad2 replicon was produced which contained the Gluc sequence and was termed rPad2GL (Fig. 1 ). This luciferase is secreted by cells and hence can be assayed within the cell medium, without harvesting the cells. RNA transcripts were produced from
Fig. 2. Expression of CSFV proteins by the replicons. RNA transcripts derived from Paderborn virus cDNA and its indicated derivatives were introduced into SFT-R cells using electroporation. After 24 h, the cells were fixed and stained with antibodies against the CSFV E2 (left) and NS3 protein (right) as indicated and the nuclei (all images) were visualized using DAPI. Mock-treated cells were used as a negative control. the rPad2GL replicon and introduced into cells. Medium from the cells was collected at various time intervals (up to 96 h later) and assayed for Gluc activity (Fig. 5) . Consistent with the results observed with the rPad2RL replicon (Fig.  3) , detection of Gluc activity from the rPad2GL replicon was observed from 3 h but increased significantly at 48, 72 and even 96 h. A truncated RNA transcript, rPad2GLD, lacking the 39 UTR and part of the NS5B coding sequence (Fig. 1 ), failed to replicate (Fig. 5) . Thus, the nature of the reporter protein within the replicons did not affect their utility as markers for replication of the viral RNA.
Chimeric replicons as a tool for identifying determinants of CSFV RNA replication
To analyse the role of specific regions of the CSFV genome in determining virus replication efficiency, several chimeric replicons were generated. Modifications to the Paderbornbased replicon, rPad2RL, were made by introducing the homologous regions from either an attenuated vaccine strain of CSFV (Riems strain) or from the highly virulent Koslov strain. The regions of the replicon that were modified were the NS2 and NS3 coding sequences (as one block, as in rPad2RL.R2/3 and rPad2RL.K2/3; see Fig. 6a ) or the NS5B coding sequence (as in rPad2RL.R5B and rPad2RL.K5B; Fig. 6a ). The complete genome sequences of these chimeric constructs were verified (data not shown). There were 52 and 50 aa differences between the NS2/NS3 regions of Riems and Koslov strains (out of a total of 1140 aa), respectively, compared with the Paderborn sequence while there were 46 and 41 aa differences within the respective NS5B sequences (out of 718 aa). RNA transcripts derived from each of these chimeric BACs were introduced into cells and the expression of Rluc monitored (Fig. 6b) . The chimeras containing the NS2 and NS3 sequences from the Riems and Koslov viruses were nonfunctional. However, the presence of the Koslov virus NS5B coding sequence (as in rPad2RL.K5B) significantly enhanced (approx. fourfold) the level of Rluc expression observed when compared with the parental rPad2RL (Fig.  6b) . In contrast, replacement of the Paderborn strain NS5B sequence with the equivalent region from the Riems strain (as in rPad2RLR5B) resulted in decreased Rluc production (to~30 %) compared with that obtained with the parental rPad2RL (Fig. 6b) .
DISCUSSION Targeted modification of CSFV sequences
The use of targeted modifications to sequences contained within BACs has been described by Muyrers et al. (1999) .
We recently described the use of this method to modify the IRES of the CSFV genome (Friis et al., 2012) but the system is applicable to any region of the viral cDNA (T. B. Rasmussen et al., in preparation) . The main advantage is that there are no target limitations (based either on size or on location) and no need for suitable restriction sites in the vicinity of the targeted region (Fujimoto et al., 2009) . Integration of the modified cDNA sequence into the BAC containing the viral cDNA is performed in vivo (within Escherichia coli) taking advantage of the host-cell, highfidelity DNA replication machinery, thereby making it less error-prone than in vitro PCR-based methods.
Design and properties of CSFV replicons
Many different approaches could be taken to the design of CSFV-based replicons, e.g. deletion of as much as possible of the viral sequence or a more conservative approach with maintenance of some of the structural proteins. Thus, one type of replicon (as in rPad1 and rPad1RL) had a deletion of most of the structural protein coding region (i.e. C to E2), only keeping 6 aa portions of the C and E2 proteins to enable processing of the protein junctions. The RNA transcripts were significantly shorter (either 9650 nt alone or 10 640 nt with the inclusion of the Rluc-2A sequence) than the full-length genome (12 296 nt). Analogous replicons, based on BVDV and CSFV, have been described (Behrens et al., 1998; Moser et al., 1999; Tautz et al., 1999) . A second type of replicon, as in rPad2 and rPad2RL, was based on earlier studies with BVDV replicons by I. Reimann and M. Beer (personal communication) and these molecules retained a functional E2 sequence, but deleted all of E rns . A similar E rns -deficient CSFV replicon has been described by Frey et al. (2006) . In addition, with the introduction of the Rluc-2A sequence, the resulting RNA genome (~11.9 kb) has a similar size as the complete virus genome (12.3 kb). The replicon including the E2 sequence (rPad2RL) replicated better than the replicon lacking this protein (rPad1RL) (Fig. 3) . Recent studies have indicated that E2 and NS4B can act synergistically in determining virus replication (Tamura et al., 2012) .
The CSFV-derived replicons containing the Rluc reporter are suitable for following the translation and replication of the viral RNA. The system is sufficiently sensitive to detect initial translation from RNAs that are not able to replicate (e.g. rPad2RLD, which lacks a functional RdRp) but can also monitor the much greater signal from replication-competent RNAs. The replicons function in a variety of cell lines; all the data presented here were derived from ovine cells (SFT-R) as the highest luciferase signals were detected in this cell line. However, comparable results have also been obtained in swine cells (PK-15 and SK6; data not shown). The differences in signal may reflect the efficiency of introducing the RNA into cells rather than differences in the replication efficiency within the cells.
The production of chimeric replicons, containing portions of the genomes of other strains, demonstrated that the replication efficiency of these RNAs was dependent on the source of the RdRp (NS5B). Incorporation of the NS5B sequence from the highly virulent Koslov strain into the Paderborn backbone greatly enhanced the replicationdependent expression of the reporter protein. In contrast, introduction of the NS5B from the vaccine strain (Riems) had the opposite effect and resulted in decreased reporter (Fig. 1) or the indicated derivatives (Figs 1 and 6a) were introduced into SFT-R cells by electroporation. At the indicated times, cell lysates were prepared and assayed for Rluc activity. Results are presented as the mean values (±SD) from three independent experiments in which the expression level at 3 h post-electroporation was set to 1 in each case. Inset contains the same data with a different y-axis scale.
protein expression (Fig. 6b) . This indicates that the activities of the RdRp and/or its interactions with other viral components are key determinants of replication efficiency. Chimeric replicon RNAs containing the NS2 and NS3 coding regions derived from infectious cDNAs corresponding to either the Koslov strain or the Riems26 strain within the Paderborn backbone proved to be replication defective (although the full-length sequences were verified). As NS2 is not required for RNA replication (Behrens et al., 1998; Moser et al., 1999) , this suggests some incompatibility between the NS3 proteins from the Koslov and Riems strains with the Paderborn strain components. Such an interaction with NS3 is unlikely to be with NS5B directly because including the Koslov NS5B protein coding sequence did not adversely affect replication. However, other studies have indicated a requirement for a specific amino acid motif within NS4A of BVDV for the correct functioning of NS3 as a protease (Tautz et al., 2000; Xu et al., 1997) . The presence of the non-homologous 39 UTR sequences from the Paderborn strain may be incompatible with the Koslov and Riems NS2/3 proteins as an interaction between the NS3 helicase protein and the 39 UTR has been demonstrated (Sheng et al., 2007) .
The ability to make replicons containing different reporter proteins could have utility in certain circumstances. We have shown that both Rluc and the secreted Gluc protein can each be used in this system. Other studies have used chloramphenicol acetyltransferase, within the N pro coding sequence of CSFV (Moser et al., 1999) , or firefly luciferase (Suter et al., 2011) and GFP within BVDV replicons (Reimann et al., 2003) . The luciferase reporter protein assays are highly sensitive and can cover a wide range of activities. Furthermore, the use of Gluc removes the need for harvesting the cells and allows results to be determined from a single batch of cells with a single introduction of RNA.
CONCLUSIONS
The replication of pestivirus RNA is a complex process involving multiple virus-encoded and cellular proteins in concert with the 39 UTR of both the positive and the negative strands of the viral RNA. Replicons provide a useful tool to analyse key features that determine RNA replication efficiency. However, particular factors, e.g. the NS5B protein, may influence replication in multiple ways; its activity as the RdRp is clearly critical for the process of RNA replication but its interactions with other components (e.g. RNA or protein) of the replication machinery are also likely to be very important. Chimeric replicons based on the related HCV have been used to identify determinants of replication efficiency in cells (Binder et al., 2007) , but clearly studies on virulence are difficult for this human pathogen. The observations described here with CSFV showed that exchanging the NS5B from the Paderborn strain (which displays intermediate virulence) with that of the highly virulent Koslov strain increased replication significantly. Thus, these replicons may be a useful tool for identifying candidate features of the virus that determine replication in the natural host. There are 41 aa differences (out of a total of 718 aa) between the RdRp from the Koslov and Paderborn strains. Identifying which of these differences are involved in determining replication efficiency in cells and if these are sufficient to confer a difference in virulence within CSFV-infected pigs is clearly important.
In addition, the lack of replication observed with chimeric RNAs containing the NS2 and NS3 coding sequences from the Koslov and Riems strains can also be informative for identifying interactions between these sequences and other virus components. It is known that the pestivirus NS3 protein interacts with other virus proteins, e.g. NS4A (Tautz et al., 1997; Xu et al., 1997) and NS5B (Wang et al., 2010) , and thus the construction of further chimeras could be used to identify other interactions and to define them at the individual amino acid level.
METHODS
Cells. The SFT-R cell line was grown at 37 uC (5% CO 2 ) in Dulbecco's minimal essential medium (DMEM) supplemented with 5 % FCS.
CSFV cDNA. The cDNA clone of the CSFV-Paderborn strain, designated pBeloPader10, has been described previously . It was maintained within E. coli strain DH10B T1 R (phenotype streptomycin-resistant; Invitrogen) and grown on selective medium containing 15 mg chloramphenicol ml
21
.
Modification of the CSFV cDNA by targeted recombination.
Modifications to the full-length CSFV cDNA were accomplished using a counter-selection BAC modification kit (GeneBridges) as described elsewhere (Friis et al., 2012; T. B. Rasmussen et al., in preparation) . All primers for the targeted recombination are listed in Table S1 available in JGV Online. Detailed information about recombination procedures is available on request.
(i) Counter-selection of rpsL/neo cassettes to form replicons. To make the intermediate constructs pBeloPadrpsL1 and pBeloPadrpsL2, containing the rpsL/neo selection cassette, the primer sets NproCrpsLFor with E2P7rpsLRev1 and Erns1787rpsLFor with ErnsE1rpsLRev2 were used. The replacement with reporter gene coding sequence was also achieved through targeted recombination. PCR products, including the Rluc-2A coding sequence and with homology arms identical to the Paderborn genome target, were generated by standard PCRs. Deletion of the coding region for C to E2 (D nt 896-3541) and introduction of the Rluc sequence was achieved by production of a fragment (P10delCtoE2_RLuc2A,~1100 bp) using primers Pader10NproCRLucFor and Pader10P7E2_2A_RLucRev with plasmid pRBRluc (Belsham et al., 2008) as template. Similarly, introduction of the Rluc-2A, with deletion of the coding region for C to E1 (D nt 974-2329), was achieved using a PCR product (fragment P10delCtoE1_Rluc2A,~1100 bp) which was produced using primers Pader10C974RLucFor and Pader10E12329_2A_RlucRev. Deletion mutants without the Rluc-2A insertions were made in the same way except that recombination was achieved using single-stranded oligonucleotides P10_DelCtoE2 and P10_DelCtoE1. A replicationdeficient version of the rPad2RL replicon was made by making an inframe deletion using two HindIII restriction sites in the Paderborn cDNA; the sites (nt 9401 and 11 728) are located in the NS5A and NS5B coding regions.
(ii) Construction of replicon containing the Gluc coding sequence.
The Gluc replicon was constructed using a combination of the counter-selection approach and a modified version of the protocol for target-primed plasmid amplification (Wei et al., 2004; Stech et al., 2008; Friis et al., 2012) . Megaprimer P10delCtoE1_Gluc2A (~700 bp) was made using primers P10C974GLuc_Fw and P10E12329GLuc2A_Rev in a standard PCR using pCMV-Gaussia Luc (Thermo Scientific) as template and Phusion hot start II HF DNA polymerase (Thermo Scientific). The megaprimer PCR used 200 ng megaprimer P10delCtoE1_ Gluc2A and 100 ng Dam+ pBeloPadrpsL2 template with 10 ml HF buffer, 1 ml dNTPs (10 mM) and 1 ml Phusion hot start II HF DNA polymerase and water to 50 ml. PCR conditions were: 98 uC for 30 s, followed by 20 cycles of 98 uC for 10 s, 48 uC for 60 s and 72 uC for 20 min, one cycle of 72 uC for 20 min, and hold at 4 uC. The PCR products were digested with DpnI, purified using a GeneJET PCR purification kit (Thermo Scientific) and electroporated into DH10B Electromax cells. Colonies were selected on agar containing 15 mg chloramphenicol ml 21 plus 50 mg streptomycin ml
, and the BAC DNAs were analysed. An amplicon corresponding to the replicationdeficient version of rPad2GL, termed rPad2GLD ( Fig. 1 ), was made with reverse primer Pan-CSF-11682-R and used to produce an RNA transcript lacking the 39 UTR and part of the NS5B coding sequence.
(iii) Production of chimeric CSFV replicons. For the generation of chimeric replicons, cDNAs corresponding to the coding sequences for NS2/3 and NS5B from the Koslov and Riems virus strains were generated. The NS2/3 sequences from the Koslov and Riems strains were amplified using primers BbP10_PaKosRi_p7_NS2_F and BbP10_PaKosRi_NS3_4_R using BAC templates, containing fulllength CSFV cDNAs, pBeloKos10 (U. Fahnøe et al., in preparation) and pBeloRiems26 (T. B. Rasmussen et al., in preparation) , respectively. The pBeloKos10 sequence encodes NS2/3 and NS5B protein sequences, which are 100 % identical to that predicted from the Koslov sequence (GenBank accession no. HM237795) but RNA transcripts derived from this BAC are replication defective due to mutations elsewhere in the cDNA. The pBeloRiems26 is derived from a variant of the Riemser/C-strain vaccine strain and generates an infectious RNA transcript. The PCR products (~3500 bp) were generated using Phusion hot-start II HF DNA polymerase and cycling conditions were as follows: 98 uC for 30 s, followed by 35 cycles of 98 uC for 10 s, 59 uC for 20 s and 72 uC for 165 s, one cycle of 72 uC for 165 s, and hold at 4 uC. Similarly, the NS5B coding sequences (~2200 bp) were amplified from pBeloKoslov10 and pBeloRiems26 using primers BbP10_PaKosRi_NS5B_F and BbP10_KosRi _NS5B_R using similar PCR conditions. Introductions of the PCR amplicons into pBelorPad2RL were carried out using the MegaPCR approach as described above.
Template production and in vitro transcription. Amplicons corresponding to the replicon cDNAs were generated, using the BACs as templates, using the long PCR method (Rasmussen et al., 2008 as follows: 5 ml PCR buffer I, 1 ml forward primer (59Paderborn T7_NotI) and 1 ml reverse primer (39Paderborn) (200 mM each), 2 ml BAC template (~25 ng), 0.5 ml AccuPrime Taq DNA Polymerase High Fidelity (Invitrogen) and water to 50 ml. To increase the yield, each reaction was performed in triplicate and pooled prior to column purification. The PCR products (~9-12.3 kb) were purified using the GeneJET PCR clean-up kit and eluted in 26 20 ml diethylpyrocarbonate (DEPC)-treated water at 65 uC.
In vitro transcription reactions were carried out using the MEGAscript T7 RNA transcription kit (Ambion). For a 20 ml reaction, 0.5 mg of the PCR product was used. Incubation was performed at 37 uC for 3 h. RNA was purified using a MEGAclear kit (Ambion), eluted in 110 ml DEPC-treated water (95 uC). RNA was evaluated using gel electrophoresis in a 1 % Tris/borate/EDTA agarose gel containing 10 000-fold-diluted SYBRsafe gel stain (Life Technologies) and the yield was quantified using a NanoDrop. The RNA was stored at 280 uC until use.
Replicon assay procedure. For each replicon to be assayed, 1 ml SFT-R cells (2610 6 ml
) was centrifuged and resuspended in the same volume of cold PBS and kept on ice. An aliquot (800 ml, 1.6610 6 cells) was transferred to a 0.4 cm cuvette (Bio-Rad) and 2.5 mg RNA was added, briefly mixed and introduced into the cells by electroporation (950 mF and 180 V on a Gene Pulser XCell; Bio-Rad) essentially as described elsewhere (Gallei et al., 2005) . After electroporation, cells were allowed to settle at room temperature for 10 min before seeding into six-well plates [250 ml per well (~5.0610 5 cells) with 3 ml DMEM containing 5 % FCS].
Alternatively, for simultaneous harvesting of samples for Rluc, Western blot analysis and immunofluorescence staining, the assay procedure for six-well plates was adapted to 24-well plates: using 50 ml (~1.0610 5 cells) per well electroporated with 500 ng RNA and with 600 ml DMEM (5 % FCS). Adding the cells to the medium was considered the assay starting point, T 0 . Plates were then incubated at 37 uC in 5 % CO 2 . After 3, 12 and 24 h, the medium was removed and monolayers were washed once with 16 Dulbecco's PBS (DPBS; Gibco) and either frozen at 280 uC or lysed immediately.
Rluc and Gluc assays. Plates were thawed at room temperature, the cells were lysed by adding 400/80 ml (for 6-or 24-well assays, respectively) of 16 Renilla Luciferase Assay Lysis buffer (Promega) to each well and incubated at 37 uC for~15-30 min. Lysates were harvested and luciferase activity was quantified in a Bio-orbit 1253 Luminometer (Aboatox) by adding 20 ml lysate into 100 ml coelentarazine substrate diluted 1 : 100 in Renilla Luciferase Assay buffer (Promega). Assays were performed in triplicate. For the Gluc replicon assays, at the indicated times, 50 ml of medium was removed from the cells and frozen at 220 uC. After thawing, 20 ml was assayed as described above.
Immunofluorescence imaging. At 24 h post-electroporation, cells were stained for the detection of E2 and NS3 antigens by immunofluorescence using mAbs WH303 and WB103/105, respectively (AHVLA Scientific) as previously described (Friis et al., 2012; Reimann et al., 2003) . The presence of E2 and NS3 and the cell nuclei were visualized using a goat anti-mouse Alexa Fluor 488-conjugated secondary antibody (Molecular Probes) and DAPI (VectaShield; Vector Laboratories), respectively. Images were taken using a BX63 fluorescence microscope (Olympus).
Western blot analysis. Lysates for Western blot analysis were prepared at 24 h post-electroporation. Cells were washed with DPBS and lysed by adding 400 or 80 ml (for six-and 24-well assays, respectively) of Buffer C [0.125 M NaCl, 20 mM Tris/HCl (pH 8.0) 0.5 % NP-40] and clarified by centrifugation (18 000 g for 5 min). Samples of the supernatants were mixed with Laemmli sample buffer, heated to 100 uC for 5 min and analysed using SDS-PAGE (12.5 % polyacrylamide) and electroblotting onto PVDF membranes (Millipore). After blocking in PBS containing 0.1 % Tween-20 and 5 % non-fat dry milk overnight, membranes were incubated for 3 h with primary antibodies [anti-Rluc (Millipore) and anti-actin (Abcam)] diluted in blocking buffer. Immunoreactive proteins were visualized on a Bio-Rad Chemi-Doc XRS system using species-specific anti-Ig secondary antibodies conjugated to HRP (P0161 and P0448; Dako) and a chemiluminescence detection system (ECL Select; Amersham).
DNA sequencing. Full-genome sequencing was performed on all the replicon cDNAs within the BACs and the expected sequences were obtained. This was performed by full-length PCR amplification of each construct. The product was purified on a PCR clean-up spin column and measured on a NanoDrop machine. Subsequently, 500 ng of each product was sequenced on an Ion Torrent PGM machine. Fastq files were checked for quality control using FastQC and later trimmed by Prinseq-lite. The BWA aligner mapped reads to the expected consensus sequence and Samtools obtained construct sequences. Finally, sequences were aligned by the MAFFT algorithm in Genious software to confirm sequences.
